HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

GMED

Globus Medical, Inc. (NYSE)

Healthcare — Medical Devices

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Buy 1.8 / 5 11 analysts
$75.96
$-3.05 (-3.86%)
Target: $108.64 (43.0%)
Sign in to add GMED to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$10.31B
P/E Ratio (TTM)17.75
Forward P/E14.76
EPS (TTM)$4.28
Dividend Yield-
Profit Margin18.92%
Revenue Growth27.00%
ROE13.30%
Debt/Equity2.45
Recommendation Buy 1.8
Analyst Target$108.64
Analysts11
Indexes NYSE

Technical Indicators

RSI (14)40.9
Beta0.95
SMA 20-
SMA 40-
52-Week High$101.40
52-Week Low$51.79
50-Day Avg$83.01
200-Day Avg$81.78
Avg Volume$1.66M
Volume$2.66M

Performance Analysis

BULLISH

GMED shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 49% of its 52-week range.
~ RSI at 40.9 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ Strong revenue growth of 27.0% year-over-year.
+ Wall Street consensus is "Buy" from 11 analysts.
+ Average analyst target of $108.64 implies 43.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:12 UTC

Back to Screener Export Report